Key Insights

Highlights

Treatment Research

1 treatments under study, led by Itf2357

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Not Yet Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05292768Not Yet Recruiting

Are Mast Cells Involved in Autoinflammatory Diseases

NCT00442182Phase 2Unknown

The Efficacy and Safety of ITF2357 in AIS

Showing all 2 trials

Research Network

Common Treatments

  • Itf23571

Active Sponsors

  • Assistance Publique - Hôpitaux de Paris1
  • Institut Imagine1
  • Radboud University Medical Center1

Top Investigators

Related Conditions

  • Autoinflammatory Disease1
  • Hids1
  • Mkd1
  • Cryopyrin Associated Periodic Syndrome1
  • Fmf1

Activity Timeline